Sigyn Therapeutics, Inc. (SIGY) stock
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Sigyn Therapeutics's shares outstanding was 2M at Sep 30, 2025. For fiscal 2024 it was 1M, up 21.1% from the year before. The highest annual figure on record is 36M in fiscal 2021.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 1M | +21.1% |
| FY2023 | Dec 31, 2023 | 1M | +17.7% |
| FY2022 | Dec 31, 2022 | 1M | -97.4% |
| FY2021 | Dec 31, 2021 | 36M | +395.1% |
| FY2020 | Dec 31, 2020 | 7M | +1256.8% |
| FY2019 | Dec 31, 2019 | 1M | +24.9% |
| FY2018 | Dec 31, 2018 | 0M | +38.2% |
| FY2017 | Dec 31, 2017 | 0M | +52.0% |
| FY2015 | Dec 31, 2015 | 0M | +10.9% |
| FY2014 | Dec 31, 2014 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | 2M | +26.5% |
| Q2 FY2025 | Jun 30, 2025 | 2M | +29.7% |
| Q1 FY2025 | Mar 31, 2025 | 2M | +30.5% |
| Q4 FY2024 | Dec 31, 2024 | 2M | +27.5% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +14.7% |
| Q2 FY2024 | Jun 30, 2024 | 1M | +14.3% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +27.9% |
| Q4 FY2023 | Dec 31, 2023 | 1M | -96.7% |
| Q3 FY2023 | Sep 30, 2023 | 1M | -97.0% |
| Q2 FY2023 | Jun 30, 2023 | 1M | -97.1% |
| Q1 FY2023 | Mar 31, 2023 | 1M | -97.4% |
| Q3 FY2022 | Sep 30, 2022 | 37M | +1.6% |
| Q2 FY2022 | Jun 30, 2022 | 37M | +2.4% |
| Q1 FY2022 | Mar 31, 2022 | 37M | +5.8% |
| Q4 FY2021 | Dec 31, 2021 | 37M | +7334.4% |
| Q3 FY2021 | Sep 30, 2021 | 37M | +7244.3% |
| Q2 FY2021 | Jun 30, 2021 | 36M | +7182.1% |
| Q1 FY2021 | Mar 31, 2021 | 35M | +6409.0% |
| Q3 FY2020 | Sep 30, 2020 | 1M | -7.7% |
| Q2 FY2020 | Jun 30, 2020 | 1M | -7.7% |
| Q1 FY2020 | Mar 31, 2020 | 1M | -7.7% |
| Q4 FY2019 | Dec 31, 2019 | 1M | +8.1% |
| Q3 FY2019 | Sep 30, 2019 | 1M | +24.2% |
| Q2 FY2019 | Jun 30, 2019 | 1M | +31.4% |
| Q1 FY2019 | Mar 31, 2019 | 1M | +40.8% |
| Q4 FY2018 | Dec 31, 2018 | 1M | +43.8% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +36.3% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +39.6% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +32.0% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +51.9% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +39.6% |
| Q2 FY2017 | Jun 30, 2017 | 0M | +29.2% |
| Q1 FY2017 | Mar 31, 2017 | 0M | +36.3% |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
| Q2 FY2016 | Jun 30, 2016 | 0M | – |
| Q1 FY2016 | Mar 31, 2016 | 0M | – |
| Q4 FY2015 | Dec 31, 2015 | 0M | – |
See a number that looks wrong?